| Basic data |
|---|
| OCA1. Surname awarded to the assessed person | Bago Pilátová |
|---|
| OCA2. Name awarded to the assessed person | Martina |
|---|
| OCA3. Degrees awarded to the assessed person | Assoc. prof. , DVM, PhD |
|---|
| OCA4. Hyperlink to the entry of the person in the Register of university staff | https://www.portalvs.sk/regzam/detail/15102 |
|---|
| OCA5. Area of assessment | study programme pharmacy (joint study programme) · I. + II. degree |
|---|
| OCA6. Category of the research/artistic/other output | scientific output |
|---|
| OCA7. Year of publication of the research/artistic/other output | 2010 |
|---|
| OCA8. ID of the record in the Central Registry of Publication Activity (CRPA) or the Central Registry of Artistic Activity (CRAA) | UPJŠ.Košice..000040248 |
|---|
| OCA9. Hyperlink to the record in CRPA or CRAA | |
|---|
| Characteristics of the output that is not registered in CRPA or CRAA |
|---|
| OCA10. Hyperlink to the record in another publicly accessible register, catalogue of research/ artistic/other outputs | http://www.crepc.sk/portal?fn=*recview&uid=131432&pageId=resultform&full=0 |
|---|
| OCA11. Characteristics of the output in the format of the CRPA or the CRAA bibliographic record, if the output is not available in a publicly accessible register or catalogue of outputs | Pilátová Martina, Varinská Lenka, Perjési Pál, Šarišský Marek, Mirossay Ladislav, Solár Peter, Ostró Alexander, Mojžiš Ján: In vitro antiproliferative and antiangiogenic effects of synthetic chalcone analogues. Toxicology in Vitro. - ISSN 0887-2333. - Vol. 24, no. 5 (2010), s. 1347-1355. |
|---|
| OCA12. Type of the output (if the output is not registered in CRPA or CRAA) | article |
|---|
| OCA13. Hyperlink to the webpage where the output is available (full text, other documentation, etc.) | https://www.sciencedirect.com/science/article/pii/S0887233310000962?via%3Dihub |
|---|
| OCA14. Characteristics of the author's contribution | |
|---|
| OCA15. Annotation of the output with contextual information concerning the description of creative process and the content of the research/artistic/other activity, etc. | |
|---|
| Other data |
|---|
| OCA16. Annotation of the output in English | Chalcones have a wide range of biologically beneficial properties, so we studied E-2- (4\\\'-methoxybenzylidene) -1-benzosuberone and its antiproliferative effects on Jurkat and HeLa cells and antiangiogenic effects on HUVEC (Human umbilical vein endothelial cells). After incubation of the tumor cells with the tested chalcone, there was a blockade in the G2 / M phase of the cell cycle and subsequent apoptosis associated with DNA fragmentation, downregulation of antiapoptotic Bcl-2 and ovrexpression of proapototic Bax. In HUVEC cells at non-toxic concentrations, it inhibited VEGF-induced migration and decreased the production of MMP-9 and VEGF. Based on these results, we can assume that this compound has antiproliferative and antiangiogenic properties. |
|---|
| OCA17. List of maximum 5 most significant citations corresponding to the output | RODRIGUES, J. et al. New 4-Maleamic Acid and 4-Maleamide Peptidyl Chalcones as Potential Multitarget Drugs for Human Prostate Cancer. In Pharmaceutical Research, 2011, vol. 28, no. 4, p. 907-919. doi: 10.1007/s11095-010-0347-8. (IF=4,981)
RUIZ-MONTAÑEZ, G. et al. Screening antimutagenic and antiproliferative properties of extracts isolated from Jackfruit pulp (Artocarpus heterophyllus Lam). In Food Chemistry, 2015, vol. 175, s. 409-416. doi: 0.1016/j.foodchem.2014.11.122. (IF 4,192)
WANGNGAE, S. et al. Photophysical study and biological applications of synthetic chalcone-based fluorescent dyes. In Molecules, 2021, roč. 26, č. 10, art. no. 2979. doi:10.3390/molecules26102979. (IF=4,148)
MIELCKE, T.R. et al. Activity of novel quinoxaline-derived ... In European Journal of Medicinal Chemistry, 2012, vol. 48, no. 2, s. 255-264. doi:10.1016/j.ejmech.2011.12.023. (IF=3,996)
SHARMA, R. et al. A review on mechanisms of anti tumor activity of chalcones. In Anti-Cancer Agents in Medicinal Chemistry, 2016, vol. 16, no. 2, s. 200-211. doi: 10.2174/1871520615666150518093144. (IF=2,617) |
|---|
| OCA18. Characteristics of the output's impact on socio-economic practice | Many currently used drugs have been created by structural modification of natural substances, which play an important role in the treatment of many diseases, including cancer. Despite advances in the diagnosis and development of new treatments, cancer is one of the most common causes of death. Their current therapy is associated with a number of side effects, which is related to its non-selective action. For this reason, scientific teams are trying to find new compounds with lower toxicity and a better therapeutic response. This article discusses the antiproliferative and antiangiogenic effects of newly synthesized chalcones, which could be helpful in finding new structures for anticancer drugs. |
|---|
| OCA19. Characteristics of the output and related activities' impact on the educational process | General pharmacology also includes the development of new drugs, including preclinical drugs. This issue is part of the pharmacology syllabus. The work enables medical and doctoral students to gain at least a simplified view of the complexity of the process of finding new compounds with potential antiproliferative effect in the basic preclinical screening phase in in vitro experiments at the cellular and subcellular level. |
|---|